Concepedia

Author

Marina Riggio

Experimental Medicine and Biology Institute

Also Known As

M. Riggio, Marina Riggio

19

Publications

416

Citations

9

H-Index

11

Concepts

All Affiliations

Experimental Medicine and Biology InstituteConsejo Nacional de Investigaciones Científicas y TécnicasUniversidad de Buenos AiresUniversity of Colorado Anschutz Medical CampusMagdalena Villegas de Martínez el Hospital
MR

About

Marina Riggio is an author at Experimental Medicine and Biology Institute specializing in tumor biology, breast cancer, and radiation oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

73

2

Cell Biology

2

2

73

3

Cell Signaling

2

2

73

4

Signal Transduction

2

2

73

5

Systems Biology

2

2

73

Marina Riggio

×

9

Publications

412

Citations

9

H-Index

YearCitations

AKT1 and AKT2 isoforms play distinct roles during breast cancer progression through the regulation of specific downstream proteins

Marina Riggio, María Cecilia Perrone, María Laura Polo,

Scientific Reports

2017

132

FGF2 induces breast cancer growth through ligand‐independent activation and recruitment of ERα and PRBΔ4 isoform to <i>MYC</i> regulatory sequences

Sebastián Giulianelli, Marina Riggio, Tomás Guillardoy,

International Journal of Cancer

2019

75

PI3K/AKT pathway regulates phosphorylation of steroid receptors, hormone independence and tumor differentiation in breast cancer

Marina Riggio, María Laura Polo, Matı́as Blaustein,

Carcinogenesis

2011

46

Progestin and antiprogestin responsiveness in breast cancer is driven by the <scp>PRA</scp>/<scp>PRB</scp> ratio <i>via</i><scp>AIB</scp>1 or <scp>SMRT</scp> recruitment to the <scp><i>CCND</i></scp><i>1</i> and <scp><i>MYC</i></scp> promoters

Victoria Wargon, Marina Riggio, Sebastián Giulianelli,

International Journal of Cancer

2014

38

Targeting mTOR to overcome resistance to hormone and CDK4/6 inhibitors in ER-positive breast cancer models

María Jimena Rodriguez, María Cecilia Perrone, Marina Riggio,

Scientific Reports

2023

29

Responsiveness to PI3K and MEK Inhibitors in Breast Cancer. Use of a 3D Culture System to Study Pathways Related to Hormone Independence in Mice

María L. Polo, Maria Victoria Arnoni, Marina Riggio,

PLoS ONE

2010

27

Activation of PI3K/Akt/mTOR signaling in the tumor stroma drives endocrine therapy-dependent breast tumor regression

María Laura Polo, Marina Riggio, María May,

Oncotarget

2015

27

Molecular mechanisms underlying AMH elevation in hyperoestrogenic states in males

Clara Valeri, María M. Lovaisa, Chrystèle Racine,

Scientific Reports

2020

25

Progesterone receptor isoform ratio dictates antiprogestin/progestin effects on breast cancer growth and metastases: A role for <scp>NDRG1</scp>

María F. Abascal, Andrés Elía, Michelle Alvarez,

International Journal of Cancer

2021

13

Page 1